This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Health Stocks in Motion

Updated from 2:20 p.m. EDT

Shares of OCA (OCA) were among the worst-performing health-related stocks Tuesday, falling 38.5% after the company said its annual and first-quarter report would be delayed because of accounting errors that occurred during the first three quarters of 2004.

The business services and systems provider to orthodontic and dental practices said that it discovered errors in its calculation of patient receivables for 2004 and that patient receivables that were reported for the first three quarters of 2004 were overstated by material amounts. OCA is also reviewing a number of other accounting issues and accounts. So far, the company has identified a number of potential accounting errors from prior periods.

Lenders have agreed to extend the filing deadlines under OCA's senior credit facility until June 30. The company, however, anticipates that its financial reports will be delayed beyond June 30, which will force it to seek an additional extension of time and waiver. The extension under the credit facility, the company said, limits the amount that OCA may borrow under the line of credit -- at least until the company files its financial reports. As a result, OCA's chief executive, Bart Palmisano Sr., has agreed to extend a $2 million unsecured loan to the company. In an effort to cut costs, the company also said that it would terminate the lease on an aircraft that's owned by an affiliate of Palmisano's. The move is expected to save the company about $1.1 million annually.

Finally, OCA said that it has appointed a special committee to review certain journal entries in the company's general ledger, the circumstances under which they originated, and their impact on the company's financial statements. Moreover, the committee is reviewing certain alleged changes in data provided to the company's registered public accounting firm. Pending completion of the committee's internal review, Bart Palmisano Jr., the company's chief operating officer, has been placed on administrative leave. Shares of OCA traded down $1.55 to $2.48.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
ALOG $90.90 0.00%
AAPL $124.43 0.00%
FB $82.22 0.00%
GOOG $548.00 0.00%
TSLA $188.77 0.00%


DOW 17,776.12 -200.19 -1.11%
S&P 500 2,067.89 -18.35 -0.88%
NASDAQ 4,900.8850 -46.5560 -0.94%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs